ExpansionJul 20, 2026, 08:03 AM
Collegium to relocate corporate headquarters to Boston in Q1 2027
AI Summary
Collegium Pharmaceutical, Inc. announced plans to relocate its corporate headquarters to One Lincoln in downtown Boston during the first quarter of 2027. This strategic move reflects the company's continued evolution as a diversified biopharmaceutical firm, aiming to position it within Boston's leading healthcare and life sciences ecosystem. The new headquarters will support future growth and reinforce Collegium's long-standing commitment to Massachusetts, where the company was founded.
Key Highlights
- Collegium Pharmaceutical will relocate its corporate headquarters.
- New headquarters will be at One Lincoln in downtown Boston.
- Relocation is scheduled for the first quarter of 2027.
- Move reflects company's evolution as a diversified biopharmaceutical firm.
- Aims to engage with Boston's healthcare and life sciences ecosystem.
- Reinforces commitment to Massachusetts, where Collegium was founded.
- DivcoWest owns and manages the One Lincoln property.
Price Impact
More from COLL